 <h1>Alitretinoin topical Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of alitretinoin topical include:</b> pain, pruritus, and skin rash. <b>Other side effects include:</b> exfoliative dermatitis, disorder of integument, and skin edema.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to alitretinoin topical: topical gel/jelly</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, alitretinoin topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking alitretinoin topical:</p><p>
<i>More common</i>
</p><ul>
<li>Abrasion of skin</li>
<li>blisters on skin</li>
<li>burning pain</li>
<li>cracking, crusting, drainage, or oozing of the skin</li>
<li>groove in the skin</li>
<li>peeling of skin</li>
<li>severe rash</li>
<li>skin redness</li>
<li>sloughing of skin</li>
<li>swelling at the site of application</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Stinging or tingling of skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of alitretinoin topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Itching</li>
<li>rash</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Increased sensitivity to the sun</li>
</ul><p>
<!-- end topical gel/jelly --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alitretinoin topical: topical gel</i></p><h3>General</h3><p>The most frequently reported side effects occurred almost exclusively at the application site.  Dermal toxicity began as erythema, which could worsen and result in edema with continued use.  This toxicity may be treatment-limiting, with intense erythema, edema, and vesiculation.  Side effects were typically mild to moderate in severity and led to study withdrawal in 7% of patients.  During one study, severe local (application site) skin reactions were reported in about 10% of patients.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Rash (up to 77%), pain (34%), paresthesia (up to 22%), pruritus (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Exfoliative dermatitis, skin disorder, edema<sup>[Ref]</sup></p><p>Side effects occurred almost exclusively at the application site and have included application site rash (term includes erythema, scaling, irritation, redness, dermatitis), pain (term includes burning, pain), pruritus (term includes itching, pruritus), exfoliative dermatitis (term includes flaking, peeling, desquamation, exfoliation), skin disorder (term includes excoriation, cracking, scab, crusting, drainage, eschar, fissure, or oozing), paresthesia (term includes stinging, tingling), and edema (term includes edema, swelling, inflammation).<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Panretin (alitretinoin topical)." Ligand Pharmaceuticals, San Diego, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about alitretinoin topical</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: miscellaneous topical agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alitretinoin Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Panretin</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Kaposi's Sarcoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alitretinoin topical: topical gel</i></p><h3>General</h3><p>The most frequently reported side effects occurred almost exclusively at the application site.  Dermal toxicity began as erythema, which could worsen and result in edema with continued use.  This toxicity may be treatment-limiting, with intense erythema, edema, and vesiculation.  Side effects were typically mild to moderate in severity and led to study withdrawal in 7% of patients.  During one study, severe local (application site) skin reactions were reported in about 10% of patients.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Rash (up to 77%), pain (34%), paresthesia (up to 22%), pruritus (up to 11%)</p><p><b>Common</b> (1% to 10%): Exfoliative dermatitis, skin disorder, edema<sup>[Ref]</sup></p><p>Side effects occurred almost exclusively at the application site and have included application site rash (term includes erythema, scaling, irritation, redness, dermatitis), pain (term includes burning, pain), pruritus (term includes itching, pruritus), exfoliative dermatitis (term includes flaking, peeling, desquamation, exfoliation), skin disorder (term includes excoriation, cracking, scab, crusting, drainage, eschar, fissure, or oozing), paresthesia (term includes stinging, tingling), and edema (term includes edema, swelling, inflammation).<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Panretin (alitretinoin topical)." Ligand Pharmaceuticals, San Diego, CA. </p><h2>More about alitretinoin topical</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: miscellaneous topical agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alitretinoin Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Kaposi's Sarcoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>